startribune.com

Investors including Bezos purchase majority stake in tumor-fighting medtech company for $2.25 billion

Frank Precopio, right, a clinical education specialist, works with John Stratmann, principal education specialist, on a part of the user interface called fusion which blends a CT scan with the live ultrasound to make tumor targeting easier with the Edison system at HistoSonics in Plymouth on Aug. 9, 2024. (Leila Navidi)

Read full news in source page